Control da Regulación Xénica en Enfermidades
Regulación Xénica
![Foto de Francisco Javier](/img/nophoto.png)
Francisco Javier
Rodríguez Berrocal
Publicacións nas que colabora con Francisco Javier Rodríguez Berrocal (10)
2022
-
Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs
Cancers, Vol. 14, Núm. 19
2014
-
Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung disease
Scientific Reports, Vol. 4
-
Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients
PLoS ONE, Vol. 9, Núm. 9
2010
2009
-
Soluble CD26 levels and its association to epidemiologic parameters in a sample population
Disease Markers, Vol. 27, Núm. 6, pp. 311-316
2008
-
How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer
Anticancer Research, Vol. 28, Núm. 4 C, pp. 2333-2341
2007
-
Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma
British Journal of Cancer, Vol. 96, Núm. 10, pp. 1569-1578
2003
-
Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early diagnosis of colorectal cancer
Disease Markers, Vol. 19, Núm. 6, pp. 267-272
2001
-
Cell surface human α-L-fucosidase
European Journal of Biochemistry, Vol. 268, Núm. 11, pp. 3321-3331
2000
-
Preoperative serum CD26 levels: Diagnostic efficiency and predictive value for colorectal cancer
British Journal of Cancer, Vol. 83, Núm. 9, pp. 1139-1146